1) Shawver LK, Slamon D, Ullrich A : Smart drugs : tyrosine kinase inhibitors in cancer therapy. Cancer Cell 1 : 117-123, 2002.
2) Drevs J, Medinger M, Schmidt-Gersbach C, Weber R, Unger C : Receptor tyrosine kinases : the main targets for new anticancer therapy. Curr Drug Targets 4 : 113-121, 2003.
5) Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E et al. : Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344 : 1031-1037, 2001.